Global Pta Balloon Catheter Market
PTA Balloon Catheter Market Size And Forecast
According to Verified Market Research, the Global PTA Balloon Catheter Market was valued at USD 2.28 Billion in 2018 and is projected to reach USD 4.8 Billion by 2026, growing at a CAGR of 9.7% from 2019 to 2026.
Global PTA Balloon Catheter Market Outlook
Increasing prevalence of cardiovascular disorders and peripheral artery disease, growing geriatric population, and rising minimally invasive surgeries are the major key factors expected to fuel the growth of PTA balloon catheter market. Moreover, rising hospitalization with increase in cardiovascular disorders is expected to rise the adoption of PTA balloon catheter. Furthermore, increasing production of PTA balloon catheter, increasing number of FDA approval to the product are expected to propel the growth of the global market. For instance, in April 2018, Medtronic Inc, IN. PACT Admiral Paclitaxel coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter received the U.S. FDA approval. However, the risks and complications associated with catheters might stagnate the growth of the market.
Global PTA Balloon Catheter Market Competitive Landscape
The Global PTA Balloon Catheter Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as Medtronic plc, Terumo Corporation, Cook Medical, Cardinal Health, Boston Scientific Corporation, Biotronik, Natec Medical, Andratec, Surmodics, Inc., and Abbott.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.